Citation: Pg. Speck et al., IN-VIVO COMPLEMENTATION STUDIES OF A GLYCOPROTEIN H-DELETED HERPES-SIMPLEX VIRUS-BASED VECTOR, Journal of General Virology, 77, 1996, pp. 2563-2568
Citation: Hm. Browne et al., CHARACTERIZATION OF HERPES-SIMPLEX VIRUS TYPE-1 RECOMBINANTS WITH MUTATIONS IN THE CYTOPLASMIC TAIL OF GLYCOPROTEIN-H, Journal of General Virology, 77, 1996, pp. 2569-2573
Authors:
MCLEAN CS
DUNCAN IA
CHISHOLM SE
BOLT SL
BOURSNELL MEG
INGLIS SC
MINSON AC
SHIELDS JG
Citation: Cs. Mclean et al., LONG-TERM PROTECTION FOLLOWING VACCINATION WITH A GH-DELETED HERPES-SIMPLEX VIRUS TYPE-1, Journal of cellular biochemistry, 1995, pp. 312-312
Authors:
FARRELL HE
MCLEAN CS
HARLEY C
EFSTATHIOU S
INGLIS S
MINSON AC
Citation: He. Farrell et al., VACCINE POTENTIAL OF A HERPES-SIMPLEX VIRUS TYPE-1 MUTANT WITH AN ESSENTIAL GLYCOPROTEIN DELETED, Journal of virology, 68(2), 1994, pp. 927-932
Citation: Dw. Wilson et al., MUTATIONS IN THE CYTOPLASMIC TAIL OF HERPES-SIMPLEX VIRUS GLYCOPROTEIN-H SUPPRESS CELL-FUSION BY A SYNCYTIAL STRAIN, Journal of virology, 68(11), 1994, pp. 6985-6993
Authors:
MCLEAN CS
ERTURK M
JENNINGS R
NICHALLANAIN D
MINSON AC
DUNCAN I
BOURSNELL MEG
INGLIS SC
Citation: Cs. Mclean et al., PROTECTIVE VACCINATION AGAINST PRIMARY AND RECURRENT DISEASE CAUSED BY HERPES-SIMPLEX VIRUS (HSV) TYPE-2 USING A GENETICALLY DISABLED HSV-1, The Journal of infectious diseases, 170(5), 1994, pp. 1100-1109